FDA inspection
Novartis Pharmaceutical Manufacturing GmbH: FDA inspection ending Mar 22, 2024
FDA inspection 1249686 · Kundl
Key facts
| Inspection ID | 1249686 |
|---|---|
| Firm | Novartis Pharmaceutical Manufacturing GmbH |
| FEI number | 3027031635 |
| Address | Biochemiestrase 10 |
| City | Kundl |
| Fiscal year | 2024 |
| Inspection end date | Mar 22, 2024 |
| Project area | Vaccine, Allergenic, and Live Biotherapeutic Products |
| Product type | Biologics, Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data